The Megyn Kelly Show

Fighting the Swamp and Conflicts of Interest, Truth About DOGE Cuts, and Finding Autism Cause, with FDA Commissioner Dr. Marty Makary | Ep. 1051

66 snips
Apr 17, 2025
Dr. Marty Makary, the new FDA Commissioner, discusses his fresh insights just weeks into his role. He highlights the need to reform FDA practices amidst concerns about corruption and Big Pharma. The conversation dives into the alarming rise of chronic diseases and autism, promoting a holistic understanding of health through nutrition. Makary emphasizes transparency in drug approvals and the importance of trust post-COVID. He also shares exciting collaborations and innovative health strategies, blending humor with serious public health reform.
Ask episode
AI Snips
Chapters
Transcript
Episode notes
INSIGHT

FDA's Siloed Culture Needs Change

  • FDA's culture is siloed, with disconnected IT systems causing inefficiencies.
  • Makary aims to unify teams around scientific gold standards and common sense.
INSIGHT

Importance of Real-Time Drug Monitoring

  • Post-approval monitoring of drugs was poor, causing delayed discovery of harms.
  • Big health data now enables real-time monitoring for safety signals and efficacy.
INSIGHT

Removing Pharma from Advisory Committees

  • FDA will remove big pharma employees from advisory committees to prevent conflicts.
  • Patients and family caregivers will replace them as voting members for independence.
Get the Snipd Podcast app to discover more snips from this episode
Get the app